| Identification | Back Directory | [Name]
(2R)-2-methyl-3-pyrrolidin-1-yl-1-[4-(trifluoromethyl)phenyl]propan-1-one hydrochloride | [CAS]
116287-13-9 | [Synonyms]
Lanperisone hydrochloride
(2R)-2-methyl-3-pyrrolidin-1-yl-1-[4-(trifluoromethyl)phenyl]propan-1-one hydrochloride
(2R)-2-Methyl-3-(1-pyrrolidinyl)-1-[4-(trifluoromethyl)phenyl]-1-propanone hydrochloride | [Molecular Formula]
C15H19ClF3NO | [MDL Number]
MFCD00874295 | [MOL File]
116287-13-9.mol |
| Hazard Information | Back Directory | [Uses]
Lanperisone hydrochloride is a novel oral muscle relaxant with anticancer activity. Lanperisone hydrochloride produces non-apoptotic cell death by inhibiting monosynaptic and polysynaptic reflex potentials. Lanperisone hydrochloride is also believed to play an important role in the dysregulation of iron metabolism and antioxidant systems to modulate processes associated with ischemic stroke[1]. | [Definition]
ChEBI: Lanperisone hydrochloride is the hydrochloride salt of lanperisone. It is a muscle relaxant. It has a role as an antineoplastic agent, a ferroptosis inducer, a muscle relaxant, a voltage-gated sodium channel blocker and a calcium channel blocker. It contains a lanperisone(1+). | [References]
[1] Progress of Ferroptosis in Ischemic Stroke and Therapeutic Targets DOI:10.1007/s10571-024-01457-6 |
|
| Company Name: |
Achemica
|
| Tel: |
+41 (24) 466-2929 |
| Website: |
www.achemica.com |
|